Leah Lawrence

Changes to prior authorization policies can increase the likelihood that patients will delay or stop filling prescriptions for oral anticancer drugs.

Adding pembrolizumab to first-line treatment with lenvatinib did not improve outcomes in a phase 3 trial of patients with advanced HCC.

Adding toripalimab to first-line chemotherapy improved survival in patients with recurrent or metastatic nasopharyngeal carcinoma.

Oncologists may often provide imprecise survival estimates for patients with advanced cancer, a new study suggests.

Changes in PROs 1 month after starting therapy may predict response and survival in patients with advanced gastrointestinal cancers.

Continuous use of low-dose aspirin is associated with an increased risk of certain cancers and a decreased risk of other cancers, data suggest.

A multi-ancestry genome-wide association study has revealed more than 180 novel genetic variants associated with prostate cancer.

Pediatric cancer survivors treated with abdominopelvic region radiotherapy have an increased risk of colorectal cancer, a study suggests.

Neoadjuvant treatment with toripalimab and axitinib has demonstrated efficacy in a phase 2 trial of patients with resectable mucosal melanoma.

The proportion of patients with breast cancer who have metastatic disease at diagnosis is lowest in North America and highest in sub-Saharan Africa, a meta-analysis suggests.